Irreconcilable contradictions in expert testimony prevented a product liability plaintiff from establishing that Merck failed to provide adequate warnings with the osteoporosis drug Fosamax, the 2nd Circuit has ruled in affirming judgment.
The plaintiff developed osteonecrosis of the jaw (ONJ) in 2004 and 2005. She filed a failure-to-warn product liability » […]
Original post by http://lawyersusaonline.com/blog/2013/02/04/fosamax-suit-cant-proceed-based-on-sham-issue/
Report bad drivers!